China halts sale of Sun Pharma drug used to treat dementia

The National Medical Products ​Administration said a recent remote ⁠inspection found shortcomings in the company’s production processes, including in the ​prevention of ⁠contamination anfulfilmentd the quality management department’s fulfillment of duties.